NCT00370266View on ClinicalTrials.gov

Intravitreal Triamcinolone for Acute Branch Retinal Vein Occlusion

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 28, 2003

Primary Completion Date

October 31, 2007

Study Completion Date

December 31, 2007

Conditions
Branch Retinal Vein Occlusion
Interventions
DRUG

Triamcinolone

Trial Locations (1)

16666

Alireza Ramezani, MD, Tehran

All Listed Sponsors
lead

Shahid Beheshti University of Medical Sciences

OTHER

NCT00370266 - Intravitreal Triamcinolone for Acute Branch Retinal Vein Occlusion | Biotech Hunter | Biotech Hunter